Tag: JAK1 inhibitor

Elective colectomy associated with improved survival in ulcerative colitis

Upadacitinib significantly improves clinical remission rate for moderately to severely active ulcerative colitis

byJessie Willisand1 others

June 14, 2022

1. Upadacitinib led to significantly greater percentages of clinical remission compared to placebo for both induction and maintenance studies. 2. ...

Filgotinib effectively induces and maintains clinical remission in patients with ulcerative colitis

byNeel Mistryand1 others

July 9, 2021

1. At weeks 10 and 58, more patients in the filgotinib 200 mg group experienced clinical remission compared with the ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: JAK1 inhibitor

Upadacitinib significantly improves clinical remission rate for moderately to severely active ulcerative colitis

Filgotinib effectively induces and maintains clinical remission in patients with ulcerative colitis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports